SCWorx Corp. provides software solutions for the management of health care providers’ foundational business applications in the United States. More Details
+ 1 more risk
Imperfect balance sheet and overvalued.
Share Price & News
How has SCWorx's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: WORX's share price has been volatile over the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: WORX underperformed the US Healthcare Services industry which returned 54.7% over the past year.
Return vs Market: WORX underperformed the US Market which returned 12.8% over the past year.
Price Volatility Vs. Market
How volatile is SCWorx's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 months ago | Simply Wall StThose Who Purchased SCWorx (NASDAQ:WORX) Shares A Year Ago Have A 70% Loss To Show For It
6 months ago | Simply Wall StSCWorx (NASDAQ:WORX) Will Have To Spend Its Cash Wisely
7 months ago | Simply Wall StDo Directors Own SCWorx Corp. (NASDAQ:WORX) Shares?
Is SCWorx undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate WORX's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate WORX's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: WORX is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.
PE vs Market: WORX is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate WORX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: WORX is good value based on its PB Ratio (2.3x) compared to the US Healthcare Services industry average (5.1x).
How is SCWorx forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SCWorx has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of WORX’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Explore growth companies in the Healthcare industry.
How has SCWorx performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WORX is currently unprofitable.
Growing Profit Margin: WORX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: WORX is unprofitable, and losses have increased over the past 5 years at a rate of 62.3% per year.
Accelerating Growth: Unable to compare WORX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WORX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).
Return on Equity
High ROE: WORX has a negative Return on Equity (-129.48%), as it is currently unprofitable.
How is SCWorx's financial position?
Financial Position Analysis
Short Term Liabilities: WORX's short term assets ($2.3M) do not cover its short term liabilities ($4.5M).
Long Term Liabilities: WORX's short term assets ($2.3M) exceed its long term liabilities ($294.0K).
Debt to Equity History and Analysis
Debt Level: WORX's debt to equity ratio (12.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if WORX's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WORX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: WORX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 56.8% each year
What is SCWorx current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate WORX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate WORX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if WORX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if WORX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of WORX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Marc Schessel (57 yo)
Mr. Marc S. Schessel is Founder of SCWorx Corp. He serves as Chairman and Chief Executive Officer of SCWorx Corp since 2012 and its Treasurer and Secretary. He founded SCWorx’s predecessor (Primrose LLC) i ...
CEO Compensation Analysis
Compensation vs Market: Marc's total compensation ($USD914.31K) is above average for companies of similar size in the US market ($USD589.30K).
Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.
|Independent Director||0.33yr||no data||0.55% |
|Independent Director||1.92yrs||US$203.11k||0.035% |
|Independent Director||0.92yr||no data||0.54% |
Experienced Board: WORX's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 44.1%.
SCWorx Corp.'s company bio, employee growth, exchange listings and data sources
- Name: SCWorx Corp.
- Ticker: WORX
- Exchange: NasdaqCM
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$14.236m
- Shares outstanding: 9.49m
- Website: https://www.scworx.com
Number of Employees
- SCWorx Corp.
- 590 Madison Avenue
- 21st Floor
- New York
- New York
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|WORX||NasdaqCM (Nasdaq Capital Market)||Yes||Common Shares||US||USD||Feb 2019|
|4R8||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Feb 2019|
|4R8||BST (Boerse-Stuttgart)||Yes||Common Shares||DE||EUR||Feb 2019|
SCWorx Corp. provides software solutions for the management of health care providers’ foundational business applications in the United States. The company provides services related to repair, normalization ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/21 06:53|
|End of Day Share Price||2020/09/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.